Open Access
J Oral Med Oral Surg
Volume 29, Number 4, 2023
Article Number 37
Number of page(s) 10
Published online 22 January 2024
  1. Mohammed A, et al. Clinicopathologic correlation of white, non-scrapable oral mucosal surface lesions: a study of 100 cases. J Clin Diagn Res 2016;10:ZC38–ZC41. [Google Scholar]
  2. Naveen-Kumar B, Tatapudi R, et al. Various forms of tobacco usage and its associated oral mucosal lesions. J Clin Exp Dent 2016;8:e172–e177. [PubMed] [Google Scholar]
  3. Warnakulasuriya S, Johnson NW, van der Waal I. Nomenclature and classification of potentially malignant disorders of the oral mucosa. J Oral Pathol Med 2007;36:575–580. [CrossRef] [PubMed] [Google Scholar]
  4. Behura SS, Masthan MK, Narayanaswamy AB. Oral mucosal lesions associated with smokers and chewers − a case-control study in chennai population. J Clin Diagn Res 2015;9:ZC17–ZC22. [Google Scholar]
  5. Pathak H, Mohanty S, Aadithya B, Dabas J. Treatment of oral mucosal lesions by scalpel excision and platelet-rich fibrin membrane grafting: a review of 26 sites. J Oral Maxillofac Surg 2015;73:1865–1874. [CrossRef] [PubMed] [Google Scholar]
  6. Shanmugam D, Dominic N. Evaluation of bovine-derived collagen membrane in oral surgical mucosal defects. J Maxillofac Oral Surg 2018;1172–1176. [Google Scholar]
  7. Rahman A, Packiaraj I, et al. Role of collagen membrane- a comprehensive review. J Adv Med Dent Sci Res 2015;3:95–97. [Google Scholar]
  8. Poornima Sowjanya N, Rao NM, et al. Versitality of the use of collagen membrane in oral cavity. J Clin Diagn Res 2016;10:ZC30–ZC33. [PubMed] [Google Scholar]
  9. Natraj S, Guruprasad Y, Jaya Shetty PN. A comparative clinical evaluation of buccal fat pad and collagen in surgical management of OSMF. Arch Dent Sci 2011;2:17–24. [Google Scholar]
  10. Ehrenfest DM, Del Corso M, et al. Three‑dimensional architecture and cell composition of a Choukroun's platelet‑rich fibrin clot and membrane. J Periodontol 2010;81:546–555. [CrossRef] [PubMed] [Google Scholar]
  11. Sunitha R, Munirathnam N. Platelet-rich fibrin: evolution of second generation platelet concentrate. Indian J Dent Res 2008;19:42. [CrossRef] [PubMed] [Google Scholar]
  12. Dohan DM, Choukroun J, Diss A, et al. Platelet‑rich fibrin (PRF): a second‑generation platelet concentrate. Part I: Technological concepts and evolution. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:e37–e44. [CrossRef] [PubMed] [Google Scholar]
  13. Dohan DM, Choukroun J, Diss A, et al. Platelet-rich fibrin (PRF): a second generation platelet concentrate. Part III: Leukocytes activation: a new feature for platelet concentrates? Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:E51. [Google Scholar]
  14. Reibel J, Gale N, Hille J, et al. Oral potentially malignant disorders and oral epithelial dysplasia. In: El-Naggar AK, Chan JKC, Grand JR, Takata T, Slootweg PPJ, Eds. WHO Classification of Head and Neck Tumours. 4th ed. Lyon, France: IARC 2017, p. 112–5. [Google Scholar]
  15. Bessho K, Murakami K, Iizuka T. The use of a new bilayer artificial dermis for vestibular extension. Br J Oral Maxillofac Surg 1998;36:457. [CrossRef] [PubMed] [Google Scholar]
  16. Mohamad El Masri, et al. Comparison of PRF versus collagen membrane on healing of socket and bone formation (Randomized Split Mouth Design). Acta Sci Dent Sci 2018;2.7:13–22. [Google Scholar]
  17. Wang C, Ma X. Preliminary study on the healing effect of PRF for soft tissue defects in oral implants. J King Saud Univ Sci, 2020;82:21–26 [Google Scholar]
  18. Sun L, et al. A collagen-based bi-layered composite dressing for accelerated wound healing. J Tissue Viability, 2022;31:180–189. [Google Scholar]
  19. Mohanty S, Pathak H, Dabas J. Platelet rich fibrin: a new covering material for oral mucosal defects. J Oral Bio Craniofac Res 2014;4:144–146. [CrossRef] [Google Scholar]
  20. Rastogi S, Modi M, Sathian B. The efficacy of collagen membrane as a biodegradable wound dressing material for surgical defects of oral mucosa: a prospective study. J Oral Maxillofac Surg 2009;67:1600–1606. [CrossRef] [PubMed] [Google Scholar]
  21. Van der Waal I. Oral Leukoplakia; a proposal for simplification and consistency of the clinical classification and terminology. Med Oral Patol Oral Cir Bucal 2019;24:e799. [PubMed] [Google Scholar]
  22. Singh A, Kohli M, Gupta N. Platelet rich fibrin: a novel approach for osseous regeneration. J Maxillofac Oral Surg 2012;11:430–434. [CrossRef] [PubMed] [Google Scholar]
  23. Warnakulasuriya S, Kujan O, et al. Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, Convened by the WHO Collaborating Centre for Oral Cancer. Oral Diseases, 2020. [Google Scholar]
  24. Thomas G, Kunnambath R, et al. Long term outcome of surgical excision of leukoplakia in a screening intervention trial. J Indian Acad Oral Med Radiol 2012;24:126. [CrossRef] [Google Scholar]
  25. Vedtofte P, Holmstrup P, Hjørting-Hansen E, et al. Surgical treatment of premalignant lesions of the oral mucosa. Int J Oral Maxillofac Surg 1987;16:656. [CrossRef] [PubMed] [Google Scholar]
  26. El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ. WHO classification of head and neck tumours (IARC WHO classification of tumours). 4th edn. World Health Organization, 2017. [Google Scholar]
  27. Farah CS, Woo SB, Zain RB, et al. Oral cancer and oral potentially malignant disorders. Int J Dent 2014;853479. [PubMed] [Google Scholar]
  28. Huang JJ, Wallace C, Lin JY, et al. Two small flaps from one anterolateral thigh donor site for bilateral buccal mucosa reconstruction after release of submucous fibrosis and/or contracture. J Plast Reconstr Aesthet Surg 2010;63:440. [CrossRef] [PubMed] [Google Scholar]
  29. Kawase T, Kamiya M, et al. The heat-compression technique for the conversion of platelet-rich fibr in preparation to a barrier membrane with a reduced rate of biodegradation. J Biomed Mater Res. Part B, Appl Biomater 2015;103:825–831. [CrossRef] [Google Scholar]
  30. Sun X-L, Zhou Y-M, et al. The effect of platelet rich fibrin on biologic characteristics of osteoblasts. Shanghai Kou Qiang Yi Xue Shanghai J Stomatol 2015;24:61–64. [Google Scholar]
  31. Reddy SS, Prashanth R, Yashodha Devi BK, et al. Prevalence of oral mucosal lesions among chewing tobacco users: a cross-sectional study. Indian J Dent Res 2015;26:537–541. [CrossRef] [PubMed] [Google Scholar]
  32. Jayadev M, Marshal Vr, Karunakar N. Role of Platelet-rich fibrin in wound healing: a critical review. J Conserv Dent 2013;16:284. [CrossRef] [PubMed] [Google Scholar]
  33. Azar DT. Refractive surgery 3rd ed St. Louis, Elsevier Health Sciences, 2019, p. 238. [Google Scholar]
  34. Thorat M, Pradeep AR, Pallavi B. Clinical effect of autologous platelet-rich fibrin in the treatment of intra-bony defects: a controlled clinical trial. J Clin Periodontol 2011;38:925–932. [CrossRef] [PubMed] [Google Scholar]
  35. Chang YC, Zhao JH. Effects of platelet-rich fibrin on human periodontal ligament fibroblasts and application for periodontal infrabony defects. Aust Dent J 2011;56:365–371. [CrossRef] [PubMed] [Google Scholar]
  36. Saman W. Clinical features and presentation of oral potentially malignant disorders. Oral Surg Oral Med Oral Pathol Oral Radiol 2018;125:582–590. [CrossRef] [PubMed] [Google Scholar]
  37. Vijayalakshmi R, Rajmohan CS, Deepalakshmi D, Sivakami G. Use of platelet rich fibrin in a fenestration defect around an implant. J Indian Soc Periodontol. 2012;16:108–112. [CrossRef] [PubMed] [Google Scholar]
  38. Reiter D. Methods and materials for wound management. Otolaryngol Head Neck Surg 1994;110:550–556. [CrossRef] [PubMed] [Google Scholar]
  39. Kawase T. Platelet-rich plasma and its derivatives as promising bioactive materials for regenerative medicine: basic principles and concepts underlying recent advances. Odontology 2015;103.2:126–135. [CrossRef] [PubMed] [Google Scholar]
  40. M Dohan Ehrenfest D, et al. In search of a consensus terminology in the field of platelet concentrates for surgical use: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization and leukocytes. Curr Pharm Biotechnol 2012;13.7:1131–1137. [CrossRef] [PubMed] [Google Scholar]
  41. Del Corso M, Toffl er M, Ehrenfest DM, et al. Use of an autologous leukocyte and platelet-rich fibrin (L-PRF) membrane in post-avulsion sites: an overview of Choukroun's PRF. J Implant Adv Clin Dent 2010;1:27–35. [Google Scholar]
  42. Dohan DM, Choukroun J, Diss A, Dohan SL, Dohan AJ, Mouhyi J, et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part II: platelet-related biologic features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006b;101:e45e–e50. [CrossRef] [PubMed] [Google Scholar]
  43. Chignon‑Sicard B, Georgiou CA, et al. Efficacy of leukocyte‑and platelet‑rich fibrin in wound healing: a randomized controlled clinical trial. Plast Reconstr Surg 2012;130:819–829. [Google Scholar]
  44. Buser D, Chappuis V, Belser UC, Chen S. Implant placement post extraction in esthetic single tooth sites: when immediate, when early, when late? Periodontol 2000 2017;73:84–102. [CrossRef] [PubMed] [Google Scholar]
  45. Warnakulasuriya S, Ariyawardena A. Malignant transformation of oral leukoplakia − a systematic review. J Oral Pathol Med 2016;45:155–156. [CrossRef] [PubMed] [Google Scholar]
  46. Fitzpatrick SG, Hirsch SA, Gordon SC. The malignant transformation of oral lichen planus and oral lichenoid lesions: a systematic review. J Am Dent Assoc 2014;145:45–56. [CrossRef] [PubMed] [Google Scholar]
  47. Raghavendra Reddy Y, Srinath N, Nandakumar H, Rajini Kanth M. Role of collagen impregnated with dexamethasone and placentrix in patients with oral submucous fibrosis. J Maxillofac Oral Surg 2012;11:166–170. [CrossRef] [PubMed] [Google Scholar]
  48. Singh O, Gupta SS, Mosses S, Shukla S. Collagen dressing versus conventional dressings. J Cutan Aesthet Surg 2011;4:12–16. [CrossRef] [PubMed] [Google Scholar]
  49. Thoma DS, Sancho-Puchades M, Ettlin DA, Hämmerle CHF, Jung RE. Impact of collagen matrix on early healing, aesthetics and patient morbidity in oral mucosal wounds − a randomized study in humans. J Clin Periodontol 2012;39:157–165. [CrossRef] [PubMed] [Google Scholar]
  50. Charulatha V, Rajaram A. Influence of different crosslinking treatments on the physical properties of collagen membranes. Biomaterials 2003;24:759–767. [CrossRef] [PubMed] [Google Scholar]
  51. Manon‐Jensen T, Kjeld NG, Karsdal MA. Collagen‐mediated hemostasis. J Thromb Haemost 2016;14:438–448. [CrossRef] [PubMed] [Google Scholar]
  52. Kumar N, et al. Evaluation of treatment outcome after impacted mandibular third molar surgery with the use of autologous platelet-rich fibrin: a randomized controlled clinical study. J Oral Maxillofac Surg 2015;73.6:1042–1049. [CrossRef] [PubMed] [Google Scholar]
  53. Bilginaylar K, Uyanik LO. Evaluation of the effects of platelet- rich fibrin and piezosurgery on outcomes after removal of impacted mandibular third molars. Brit J Oral Maxillofac Surg 2016;54.6:629–633. [CrossRef] [Google Scholar]
  54. Uyanık LO, et al. Effects of platelet-rich fibrin and piezosurgery on impacted mandibular third molar surgery outcomes. Head Face Med 2015;11:25–32. [CrossRef] [PubMed] [Google Scholar]
  55. Al-Hamed FS, et al. Clinical effects of platelet-rich fibrin (PRF) following surgical extraction of lower third molar. Saudi J Dent Res 2017;8.1-2:19–25. [CrossRef] [Google Scholar]
  56. Kulkarni MR, Thomas BS, Varghese JM, Bhat GS. Platelet‑rich fibrin as an adjunct to palatal wound healing after harvesting a free gingival graft: a case series. J Indian Soc Periodontol 2014;18:399–402. [CrossRef] [PubMed] [Google Scholar]
  57. Mahajan M, Gupta Mk, Bande C, Meshram V. Comparative evaluation of healing pattern after surgical excision of oral mucosal lesions by using platelet rich fibrin (prf) membrane and collagen membrane as grafting materials- a randomized clinical trial. J Oral Maxillofac Surg 2018;S0278-2391:30195–2. [Google Scholar]
  58. Shanmugam M, Kumar TS, Arun KV, Arun R, Karthik SJ. Clinical and histological evaluation of two dressing materials in the healing of palatal wounds. J Indian Soc Periodontol 2010;14:241–244. [CrossRef] [PubMed] [Google Scholar]
  59. Gorell ES, Leung TH, Khuu P, Lane AT. Purified type I collagen wound matrix improves chronic wound healing in patients with recessive dystrophic epidermolysis bullosa. Pediatr Dermatol 2015;32:220–225 [PubMed] [Google Scholar]
  60. Dohan Ehrenfest DM, Diss A, Odin G, et al. In vitro effects of Choukroun's PRF (platelet‑rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;108:341–352. [CrossRef] [PubMed] [Google Scholar]
  61. Desai CB, Mahindra UR, Kini YK, Bakshi MK. Use of platelet‑rich fibrin over skin wounds: modified secondary intention healing. J Cutan Aesthet Surg 2013;6:35–37. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.